Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy
Information source: Saint Francis Care
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Hip Injuries
Intervention: liposomal bupivacaine (Drug); Bupivacaine (Drug)
Phase: N/A
Status: Recruiting
Sponsored by: Saint Francis Care Official(s) and/or principal investigator(s): Sanjay Sinha, MD, Principal Investigator, Affiliation: Saint Francis Hospital and Medical Center
Overall contact: Sanjay Sinha, MD, Email: sanjaysinha@comcast.net
Summary
This study is being undertaken to compare the pain control using either bupivacaine versus
liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up
to 72 hours while regular bupivacaine can provide pain relief up to 12 hours
Clinical Details
Official title: Comparison of Bupivacaine to Liposomal Bupivacaine for Ultrasound Guided Periarticular Hip Infiltration for Postoperative Analgesia After Hip Arthroscopy.
Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Primary outcome: Opioid consumption
Secondary outcome: Pain Scores
Detailed description:
Patients undergoing hip arthroscopy experience moderate to severe postoperative pain.
Effective pain control after surgery is an important component in the overall management of
these patients. Good pain control encourages early participation in rehabilitation program,
increases success of the surgery, and improves patient satisfaction. Typically,
postoperative analgesia is provided to these patients either with nerve blocks or opioid
medications. Both these methods provide good pain relief but nerve blocks are associated
with weakness of lower extremity muscles which interferes with early ambulation and increase
the risk of falls while narcotic medications increase the risk of nausea, vomiting, itching,
constipation, ileus, urinary retention, sedation and respiratory depression.
Eligibility
Minimum age: 18 Years.
Maximum age: 80 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients having hip arthroscopy
Exclusion Criteria:
- History of neurologic disease, neuropathy, diabetes
- Allergy to local anesthetic solution
- Chronic use of narcotics
- Inability to give consent/cooperate with study
- History of previous hip arthroscopy on the ipsilateral side
- Pregnancy
Locations and Contacts
Sanjay Sinha, MD, Email: sanjaysinha@comcast.net
Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105, United States; Recruiting Sanjay Sinha, MD, Email: sanjaysinha@comcast.net Sanjay Sinha, MD, Principal Investigator
Additional Information
Starting date: July 2013
Last updated: March 16, 2015
|